https://www.selleckchem.com/pr....oducts/dubs-in-1.htm
c.BACKGROUND Bladder cancer (BC) patients with advanced disease have poor outcomes. The use of patient-reported outcomes (PROs) could lead to improvements in symptom management and hence quality of life (QoL). The aim of this study is to report correlations between selected PROs and QoL and thus to present symptoms that influence QoL. Identification of these symptoms during treatment can lead to earlier symptom management and thus secure improvements in QoL. METHODS BC patients in chemo- or immunotherapy for locally advanced or metast
Like
Comment
Share
